Clinical and Antimicrobial Resistance Patterns of Salmonella enterica Serovar Paratyphi A Infections in Pediatric

Surendra Bahadur Mathur1, Dharmendra Kumar Singh2, Naz Perween3

  • 1Department of Pediatrics, Postgraduate Institute of Child Health, Sector - 30, Gautam Buddha Nagar, Noida, Uttar Pradesh, India. sbmathur05@gmail.com.

Indian Pediatrics
|June 22, 2026
PubMed

Insights

Pediatric Salmonella Paratyphi A infections show emerging resistance to common antibiotics like ceftriaxone. However, children responded well to tailored antimicrobial therapy, indicating favorable short-term outcomes despite resistance patterns.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance
  • Bacteriology

Background:

  • Salmonella enterica serovar Paratyphi A (SPA) infections pose a significant public health concern in children.
  • Understanding the clinical and microbiological characteristics of SPA is crucial for effective management.

Purpose of the Study:

  • To analyze the clinical profiles of pediatric SPA infections.
  • To determine antibiotic susceptibility patterns and biochemical characteristics of SPA isolates in children.

Main Methods:

  • Retrospective observational study of hospitalized pediatric patients (<18 years) with blood culture-confirmed SPA infection.
  • Data collection included demographics, clinical features, treatment, antibiotic susceptibility, and outcomes.
  • Statistical analysis performed using SPSS (P<0.05 significance).

Main Results:

  • Forty-five pediatric cases analyzed; mean age 7 years.
  • Fever, vomiting, and abdominal pain were common clinical signs.
  • Significant resistance observed to ceftriaxone (31%) and fluoroquinolones (85-100%).
  • High susceptibility noted for trimethoprim+sulfamethoxazole (100%) and chloramphenicol (90.6%).
  • Extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase production detected in 35.6% and 26.7% of isolates, respectively.

Conclusions:

  • Emerging antimicrobial resistance in pediatric SPA isolates is a growing concern.
  • Short-term clinical outcomes were favorable with appropriate antimicrobial therapy.
  • Tailored treatment strategies are essential for managing pediatric SPA infections effectively.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Reservoir of Infection01:30

Reservoir of Infection

Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...